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he neural cell adhesion molecule (NCAM) forms a
complex with p59
 
fyn
 
 kinase and activates it via a
mechanism that has remained unknown. We show
that the NCAM140 isoform directly interacts with the
intracellular domain of the receptor-like protein tyro-
sine  phosphatase RPTP
 
 
 
, a known activator of p59
 
fyn
 
.
Whereas this direct interaction is Ca
 
2
 
 
 
 independent, for-
mation of the complex is enhanced by Ca
 
2
 
 
 
-dependent
spectrin cytoskeleton–mediated cross-linking of NCAM
and RPTP
 
 
 
 in response to NCAM activation and is ac-
T
 
companied by redistribution of the complex to lipid rafts.
Association between NCAM and p59
 
fyn
 
 is lost in RPTP
 
 
 
-
deﬁcient brains and is disrupted by dominant-negative
RPTP
 
 
 
 mutants, demonstrating that RPTP
 
 
 
 is a link between
NCAM and p59
 
fyn
 
. NCAM-mediated p59
 
fyn
 
 activation is
abolished in RPTP
 
 
 
-deﬁcient neurons, and disruption of
the NCAM–p59
 
fyn
 
 complex in RPTP
 
 
 
-deﬁcient neurons or
with dominant-negative RPTP
 
 
 
 mutants blocks NCAM-
dependent neurite outgrowth, implicating RPTP
 
 
 
 as a
major phosphatase involved in NCAM-mediated signaling.
 
Introduction
 
The neural cell adhesion molecule (NCAM) is involved in
several morphogenetic events, such as neuronal migration
and differentiation, neurite outgrowth, and axon fasciculation.
NCAM-induced morphogenetic effects depend on activation of
Src family tyrosine kinases and, in particular, p59
 
fyn
 
 kinase
(Schmid et al., 1999). NCAM-dependent neurite outgrowth is
impaired in neurons from p59
 
fyn
 
-deficient mice (Beggs et al.,
1994) and is abolished by inhibitors of Src kinase family mem-
bers (Crossin and Krushel, 2000; Kolkova et al., 2000; Caval-
laro et al., 2001)
 
.
 
 The NCAM140 isoform has been observed in
a complex with p59
 
fyn
 
, whereas p59
 
fyn
 
 does not associate signif-
icantly with NCAM180 or glycosylphosphatidylinositol-linked
NCAM120 (Beggs et al., 1997)
 
.
 
 However in oligodendrocytes,
p59
 
fyn
 
 is also associated with NCAM120 in isolated lipid rafts
(Kramer et al., 1999), whereas in tumor cells NCAM is also
associated with pp60
 
c-src
 
 (Cavallaro et al., 2001), suggesting
that additional molecular mechanisms may define NCAM’s
specificity of interactions with Src kinase family members.
Several lines of evidence suggest that NCAM’s association
with lipid rafts is critical for p59
 
fyn
 
 activation. NCAM not only
colocalizes with p59
 
fyn
 
 in lipid rafts (He and Meiri, 2002) but
disruption of NCAM140 association with lipid rafts either by
mutation of NCAM140 palmitoylation sites or by lipid raft
destruction attenuates activation of the p59
 
fyn
 
 kinase pathway,
completely blocking neurite outgrowth (Niethammer et al.,
2002). However, in spite of compelling evidence that NCAM
can activate Src family tyrosine kinases, the mechanism of this
activation has remained unclear.
The activity of Src family tyrosine kinases is regulated
by phosphorylation (Brown and Cooper, 1996; Thomas and
Brugge, 1997; Bhandari et al., 1998; Hubbard, 1999; Petrone
and Sap, 2000). The two best-characterized tyrosine phosphor-
ylation sites in Src family tyrosine kinases perform opposing
regulatory functions. The site within the enzyme’s activation
loop (Tyr-420 in p59
 
fyn
 
) undergoes autophosphorylation, which
is crucial for achieving full kinase activity. In contrast, phos-
phorylation of the COOH-terminal site (Tyr-531 in p59
 
fyn
 
)
inhibits  kinase activity through intramolecular interaction
between  phosphorylated Tyr-531 and the SH2 domain in
p59
 
fyn
 
, which stabilizes a noncatalytic conformation.
A well known activator of Src family tyrosine kinases is
the receptor protein tyrosine phosphatase RPTP
 
 
 
 (Zheng et al.,
1992, 2000; den Hertog et al., 1993; Su et al., 1996; Ponniah et
al., 1999). It contains two cytoplasmic catalytic domains, D1
and D2, of which only D1 is significantly active in vitro and
in vivo (Wang and Pallen, 1991; den Hertog et al., 1993; Wu et
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al., 1997; Harder et al., 1998). To activate Src family tyrosine
kinase, constitutively phosphorylated pTyr789 at the COOH-
terminal of RPTP
 
 
 
 binds the SH2 domain of Src family tyro-
sine kinase that disrupts the intra-molecular association be-
tween the SH2 and SH1 domains of the kinase. This initial
binding is followed by binding between the inhibitory COOH-
terminal phosphorylation site of the Src family tyrosine kinase
(pTyr531 in p59
 
fyn
 
) and the D1 domain of RPTP
 
 
 
 resulting in
dephosphorylation of the inhibitory COOH-terminal phosphory-
lation sites in Src family tyrosine kinases (Zheng et al., 2000).
These sites are hyperphosphorylated in cells lacking RPTP
 
 
 
,
and kinase activity of pp60
 
c-src
 
 and p59
 
fyn
 
 in RPTP
 
 
 
-deficient
mice is reduced (Ponniah et al., 1999). Like p59
 
fyn
 
 and NCAM,
RPTP
 
 
 
 is particularly abundant in the brain (Kaplan et al.,
1990; Krueger et al., 1990), accumulates in growth cones
(Helmke et al., 1998), and is involved in neural cell migration
and neurite outgrowth (Su et al., 1996; Yang et al., 2002;
Petrone et al., 2003).
Remarkably, a close homologue of RPTP
 
 
 
, CD45, asso-
ciates with the membrane-cytoskeleton linker protein spectrin
(Lokeshwar and Bourguignon, 1992; Iida et al., 1994), a bind-
ing partner of NCAM (Leshchyns’ka et al., 2003). Following
this lead, we investigated the possibility that RPTP
 
 
 
 is in-
volved in NCAM-induced p59
 
fyn
 
 activation. We show that the
intracellular domains of NCAM140 and RPTP
 
 
 
 interact di-
rectly and that this interaction is enhanced by spectrin-medi-
ated Ca
 
2
 
 
 
-dependent cross-linking of NCAM and RPTP
 
 
 
.
Levels of p59
 
fyn
 
 associated with NCAM correlate with the
ability of NCAM-associated RPTP
 
 
 
 to bind to p59
 
fyn
 
, and the
NCAM–p59
 
fyn
 
 complex is disrupted in RPTP
 
 
 
-deficient brains
implicating RPTP
 
 
 
 as linker molecule between NCAM and
p59
 
fyn
 
. RPTP
 
 
 
 redistributes to lipid rafts in response to NCAM
activation and RPTP
 
 
 
 levels are reduced in lipid rafts from
NCAM-deficient mice, suggesting that NCAM recruits RPTP
 
 
 
to lipid rafts to activate p59
 
fyn
 
. Finally, NCAM-mediated
p59
 
fyn
 
 activation is abolished in RPTP
 
 
 
-deficient neurons and
NCAM-induced neurite outgrowth is blocked in RPTP
 
 
 
-defi-
cient neurons or neurons transfected with dominant-negative
RPTP
 
 
 
 mutants, demonstrating that RPTP
 
 
 
 is a major phos-
phatase involved in NCAM-mediated signaling.
 
Results
 
Activation of p59
 
fyn
 
 is impaired in 
NCAM-deficient brains
 
Cross-linking of NCAM at the cell surface results in a rapid ac-
tivation of p59
 
fyn
 
 kinase (Beggs et al., 1997; Niethammer et al.,
2002) via an unknown mechanism. To analyze whether or not
NCAM deficiency may affect the activation status of p59
 
fyn
 
, we
compared levels of activated p59
 
fyn
 
 characterized by dephos-
phorylation at Tyr-531 and phosphorylation at Tyr-420 in the
brains of wild-type and NCAM-deficient mice. Whereas the
level of p59
 
fyn
 
 protein was higher in brain homogenates of
NCAM-deficient mice (Fig. 1 A), labeling with antibodies rec-
ognizing only p59
 
fyn
 
 dephosphorylated at Tyr-531 or with anti-
bodies recognizing only p59
 
fyn
 
 phosphorylated at Tyr-420 was
reduced in brain homogenates of NCAM-deficient mice (Fig. 1
B), indicating that activation of p59
 
fyn
 
 is inhibited in NCAM-
deficient brains and suggesting that NCAM is involved in the
regulation of p59
 
fyn
 
 function.
Figure 1. Activated p59
fyn is reduced in
NCAM-deficient brain. (A) Brain homogenates
from 0- to 4-d-old wild-type (NCAM / ) and
NCAM-deficient (NCAM / ) mice were
probed by Western blot with antibodies
against total p59
fyn protein. Labeling for
GAPDH was included as loading control. Lev-
els of p59
fyn protein are increased in NCAM-
deficient brains. (B) p59
fyn immunoprecipitates
from 0- to 4-d-old wild-type (NCAM / ) and
NCAM-deficient (NCAM / ) mice were
probed by Western blot with antibodies
against total p59
fyn protein, p59
fyn dephos-
phorylated at Tyr-531, or p59
fyn phosphory-
lated at Tyr-420. Activated p59
fyn is reduced
in NCAM-deficient brains. Histograms (A and B)
show quantitation of the blots with OD for
wild type set to 100%. Mean values   SEM
(n   6) are shown. *, P   0.05, paired t test. 
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NCAM forms a complex with RPTP
 
 
 
The intracellular domain of NCAM does not contain sequences
known to induce p59
 
fyn
 
 activation. Thus, NCAM may form a
complex with a protein, possibly a protein tyrosine phos-
phatase, to activate p59
 
fyn
 
. One possible candidate is the
RPTP
 
 
 
 that dephosphorylates Tyr-531 of p59
 
fyn
 
 (Bhandari et
al., 1998) and is highly enriched in neurons and growth cones
(Helmke et al.,1998). Remarkably, in RPTP
 
 
 
-deficient cells,
both dephosphorylation of the COOH-terminal tyrosine residue
and autophosphorylation of the tyrosine residue within the acti-
vation loop of pp60
 
c-src
 
 is reduced (von Wichert et al., 2003),
resembling the phenotype of NCAM-deficient mice. Further-
more, a close homologue of RPTP
 
 
 
, CD45, associates with the
membrane-cytoskeleton linker protein spectrin (Lokeshwar and
Bourguignon, 1992; Iida et al., 1994), a binding partner of
NCAM (Leshchyns’ka et al., 2003). To investigate if NCAM
interacts with RPTP
 
 
 
, we analyzed the distribution of both pro-
teins in cultured hippocampal neurons. NCAM and RPTP 
partially colocalized along neurites, and both proteins accumu-
lated in growth cones where clusters of NCAM partially over-
lapped with accumulations of RPTP  (Fig. 2 A). To verify
whether or not NCAM interacts with RPTP , we induced clus-
tering of NCAM at the cell surface of live hippocampal neu-
rons by incubation with antibodies against NCAM. Clustering
of NCAM enhanced overlap between NCAM and RPTP  lo-
calization (mean correlation between NCAM and RPTP  lo-
calization being 0.3   0.05 and 0.6   0.03 in neurons treated
with nonspecific IgG or NCAM antibodies, respectively; Fig. 2 B),
indicating that RPTP  partially redistributed to NCAM clus-
ters and suggesting that NCAM and RPTP  form a complex.
Because antibodies against RPTP  were directed against its in-
tracellular domain, RPTP  contained in intracellular organelles
could have been recognized as colocalizing with NCAM that
associates with intracellular organelles of trans-Golgi network
origin (Sytnyk et al., 2002). Thus, the redistribution of RPTP 
to NCAM clusters may represent redistribution of intracellular
carriers containing RPTP . To analyze whether or not NCAM
associates with RPTP  in the plasma membrane, we transfected
neurons with RPTP  containing the HA tag in the extracellular
domain and induced clustering of NCAM and HA-RPTP  with
antibodies against NCAM and the HA tag. HA-RPTP  par-
tially redistributed to NCAM clusters (Fig. 2 C), indicating that
both proteins form a complex at the cell surface.
Finally, we examined the association between NCAM
and RPTP  in the brain by coimmunoprecipitation. RPTP 
coimmunoprecipitated with NCAM from brain homogenates
(Fig. 2 D), confirming that NCAM associates with RPTP . In-
terestingly, we found that the level of RPTP  was approxi-
mately two times higher in the brain of NCAM-deficient mice
when compared with wild-type mice (Fig. 2 D), indicating a
functional relationship between NCAM and RPTP .
NCAM140 is the most potent RPTP -
binding NCAM isoform
To identify the NCAM isoform interacting with RPTP , we
expressed NCAM120, NCAM140, and NCAM180 in CHO
cells and analyzed their association with RPTP  by coimmu-
Figure 2. NCAM forms a complex with RPTP . (A) High magnification
image of a growth cone of a hippocampal neuron labeled with antibodies
against NCAM and RPTP . Note that clusters of NCAM overlap with
accumulations of RPTP . (B) Live hippocampal neurons were treated with
nonspecific IgG or with antibodies against NCAM. Note that antibodies
against NCAM induced clustering of NCAM at the cell surface. Labeling
with antibodies against RPTP  showed that RPTP  partially redistributed to
NCAM clusters (arrows). The corresponding profiles show NCAM and
RPTP  labeling intensities along neurites. Note increased overlap of
NCAM and RPTP  clusters in neurons treated with NCAM antibodies.
(C) Hippocampal neurons transfected with wild-type RPTP  containing an
HA tag extracellularly were incubated live with antibodies against the HA
tag and NCAM. Cell surface RPTP  partially redistributed to NCAM clusters
(arrows). Bars, 10  m. (D) Brain homogenates of wild-type (NCAM / )
and NCAM-deficient (NCAM / ) mice (total brain) and NCAM immu-
noprecipitates (IP: NCAM) were probed with antibodies against RPTP  by
Western blot. Labeling for GAPDH was included as loading control.
RPTP  coimmunoprecipitates with NCAM. Note increased expression
of RPTP  in NCAM-deficient brains. Histogram shows quantitation of the
RPTP  level in wild type ( / ) and NCAM-deficient ( / ) brains. OD
for wild type was set to 100%. Mean values   SEM (n   6) are shown.
*, P   0.05, paired t test.JCB • VOLUME 168 • NUMBER 1 • 2005 130
noprecipitation. CHO cells endogenously express RPTP  that
was detected with RPTP  antibodies as a band with a molecu-
lar mass identical to RPTP  detected in brain homogenates
(unpublished data). Although transfected CHO cells expressed
NCAM120, NCAM140, and NCAM180 in similar amounts,
RPTP  coimmunoprecipitated only with NCAM140 (Fig. 3
A). However, after prolonged exposure of the film we could
also detect RPTP  in NCAM180 immunoprecipitates (un-
published data). RPTP  did not coimmunoprecipitate with
NCAM120. We conclude that RPTP  associates predomi-
nantly with NCAM140 and to a lesser extent with NCAM180.
Inability of NCAM120, the GPI-linked NCAM isoform
without the intracellular domain, to bind RPTP  suggested that
the intracellular domain of NCAM is involved in the formation
of a complex between NCAM and RPTP . Furthermore, the
extracellular domain of NCAM (NCAM-Fc) did not bind to
RPTP  in brain lysates, confirming that the extracellular domain
of NCAM does not bind to RPTP  (unpublished data). To verify
that the NCAM intracellular domain interacts directly with the
intracellular domain of RPTP , we analyzed binding of the re-
combinant intracellular domain of RPTP  to the intracellular
domain of NCAM180 or NCAM140 in a pull-down assay. For
comparison, the intracellular domain of CHL1, another adhe-
sion molecule of the immunoglobulin superfamily, was used.
The intracellular domain of RPTP  bound to the intracellular
domain of NCAM180 or NCAM140 but not to the intracellu-
lar domain of CHL1 (Fig. 3 B). Interaction between the intracel-
lular domains of RPTP  and NCAM140 was severalfold
stronger than between the intracellular domains of RPTP  and
NCAM180 (Fig. 3 B). To confirm this finding, we examined
the direct interaction between the intracellular domains of
RPTP  and NCAM180 or NCAM140 by ELISA. Intracellu-
lar domain of RPTP  bound to the intracellular domains of
NCAM180 or NCAM140 in a concentration-dependent manner,
with the intracellular domain of NCAM140 binding with a
higher affinity than the intracellular domain of NCAM180 (Fig.
3 C). No binding with the intracellular domain of CHL1 was
observed (Fig. 3 C). We conclude that NCAM binds directly to
RPTP  via the intracellular domain, with NCAM140 being the
most potent RPTP -binding NCAM isoform.
RPTP  binds NCAM140 via the D2 
domain and links NCAM140 to p59
fyn
To identify the part of the intracellular domain of RPTP  re-
sponsible for the interaction with NCAM140, we coexpressed,
in CHO cells, NCAM140 together with the wild-type form
of RPTP  (wtRPTP ), RPTP  lacking the D2 domain
(RPTP  D2), or catalytically inactive form of RPTP 
containing a mutation within the D1 catalytic domain
(RPTP C433S) and analyzed binding of NCAM140 to these
RPTP  mutants by coimmunoprecipitation. All transfected
Figure 3. Intracellular domain of NCAM140 directly interacts with the
intracellular domain of RPTP . (A) Lysates and NCAM immunoprecipitates
(IP: NCAM) from CHO cells transfected with NCAM120, NCAM140,
NCAM180, or GFP were probed by Western blot with antibodies against
NCAM and RPTP . Note that NCAM isoforms were expressed in approx-
imately equal amounts whereas RPTP  immunoprecipitated only with
NCAM140 but not NCAM180 or NCAM120. Labeling for GAPDH was
included as loading control. (B) Intracellular domains of NCAM140,
NCAM180, or CHL1 were bound to Ni-NTA agarose beads. The gel was
stained with Coomassie blue and shows that approximately equal
amounts of the intracellular domains of NCAM140, NCAM180, or CHL1
were bound to beads. Beads were incubated with equal concentrations of
intracellular domains of RPTP  and the extent of RPTP  intracellular do-
main binding was determined by Western blotting using polyclonal anti-
bodies against RPTP . Intracellular domains of RPTP  interacted with intra-
cellular domains of NCAM140, and to a lesser extent NCAM180, but
not with intracellular domains of CHL1. (C) Intracellular domains of
NCAM140, NCAM180, or CHL1 were bound to plastic and assayed by
ELISA for the ability to bind increasing concentrations of RPTP  intracellular
domains. Binding to BSA served as a control. Mean values (OD 405)  
SEM (n   6) are shown. Intracellular domains of RPTP  bound to intracellular
domains of NCAM140 and with a lower affinity to intracellular domains
of NCAM180, but not to intracellular domains of CHL1.RPTP  LINKS NCAM TO P59
FYN PATHWAY • BODRIKOV ET AL. 131
RPTP  constructs contained the HA tag to distinguish them
from endogenous RPTP . As seen for endogenous RPTP ,
transfected wtRPTP  coimmunoprecipitated with NCAM140
(Fig. 4 A). Similar amounts of RPTP C433S coimmunopre-
cipitated with NCAM140, whereas RPTP  D2 did not coim-
munoprecipitate (Fig. 4 A), indicating that the D2 domain is re-
quired for the interaction between RPTP  and NCAM140.
Remarkably, among the major NCAM isoforms, only
NCAM140 forms a complex with p59
fyn (Beggs et al., 1997)
that we found to correlate with its ability to bind RPTP  (see
the previous section). RPTP  directly interacts with p59
fyn
(Bhandari et al., 1998). Accordingly, p59
fyn coimmunoprecipi-
tated with wtRPTP  from transfected CHO cells (Fig. 4 A).
Approximately the same amount of p59
fyn coimmunoprecipi-
tated with RPTP  D2 (Fig. 4 A), indicating that this truncated
construct also binds p59
fyn probably via the D1 domain. In
accordance with previous reports, p59
fyn showed reduced abil-
ity to bind RPTP C433S, a catalytically inactive mutant of
RPTP  (Fig. 4 A; Zheng et al., 2000).
To analyze the role of RPTP  in NCAM140–p59
fyn
complex formation, we coimmunoprecipitated p59
fyn with
NCAM140 in the presence of RPTP  mutants. In CHO cells
cotransfected with NCAM140 and wtRPTP , p59
fyn coimmu-
noprecipitated with NCAM140 (Fig. 4 A). The amount of
p59
fyn coimmunoprecipitated with NCAM140 was reduced in
cells cotransfected with RPTP C433S (Fig. 4 A), correlating
with the reduced ability of this catalytically inactive RPTP 
mutant to bind p59
fyn (see previous paragraph; Zheng et al.,
2000). When NCAM140 was cotransfected with RPTP  D2,
p59
fyn no longer coimmunoprecipitated with NCAM140 (Fig.
4 A). Because RPTP  D2 binds p59
fyn (Fig. 4 A), it is con-
ceivable that this mutant, which does not bind NCAM140,
competes with endogenous RPTP  for binding to p59
fyn and
thus inhibits NCAM140–p59
fyn complex formation.
To extend this analysis to neurons, we transfected hippo-
campal neurons with GFP alone or cotransfected with GFP
and RPTP  D2 or RPTP C433S and analyzed the redistribu-
tion of p59
fyn to NCAM clusters after cross-linking NCAM
with NCAM antibodies (Fig. 4 B). In neurons transfected with
RPTP  D2 or RPTP C433S, the level of p59
fyn in NCAM
clusters was reduced by  30% when compared with
GFP only transfected cells, suggesting that RPTP  D2 or
Figure 4. RPTP  interacts with NCAM140
via D2 domain and links NCAM140 to p59
fyn.
(A) Lysates from CHO cells cotransfected
with  NCAM140 and wild-type (wt) RPTP ,
RPTP  D2, RPTP C433S, or GFP were
probed with antibodies against HA tag and
NCAM by Western blot. NCAM140 and
RPTP  constructs are expressed at approxi-
mately equal amounts in transfected CHO
cells. Labeling for GAPDH was included as
loading control. NCAM (IP: NCAM) or RPTP 
(IP: HA) immunoprecipitates were probed with
antibodies against HA tag and p59
fyn.
wtRPTP  and RPTP C433S but not RPTP  D2
coimmunoprecipitated with NCAM140.
RPTP C433S and RPTP  D2 inhibited coim-
munoprecipitation of p59
fyn with NCAM140.
p59
fyn coimmunoprecipitated with wtRPTP 
and RPTP  D2 but to a lower extent with
RPTP C433S. (B) Hippocampal neurons trans-
fected with RPTP C433S, RPTP  D2, or GFP
were incubated live with NCAM antibodies to
cluster NCAM and fixed and labeled with anti-
bodies against p59
fyn. Note that redistribution
of p59
fyn to NCAM clusters (arrows) was re-
duced in neurons transfected with RPTP C433S
or RPTP  D2. Bar, 10  m. The corresponding
profiles show NCAM and p59
fyn labeling in-
tensities along transfected neurites. The histo-
gram shows mean labeling intensity of p59
fyn in
NCAM clusters. Transfection with RPTP C433S
or RPTP  D2 reduced association between
p59
fyn and NCAM. Mean values   SEM (n  
20 neurons) are shown in arbitrary units (AU).
*, P   0.05, t test.JCB • VOLUME 168 • NUMBER 1 • 2005 132
Figure 5. NCAM–p59
fyn complex formation and NCAM-mediated p59
fyn activation are abolished in RPTP -deficient neurons. (A) p59
fyn immunoprecipitates
from 4-d-old wild-type (RPTP  / ) and RPTP -deficient (RPTP  / ) brain homogenates were probed by Western blot with antibodies against total p59
fyn
protein, p59
fyn dephosphorylated at Tyr-531, or p59
fyn phosphorylated at Tyr-420. Levels of p59
fyn dephosphorylated at Tyr-531 and p59
fyn phosphory-
lated at Tyr-420 are reduced in RPTP -deficient brains. Histograms show quantitation of the blots with OD for wild type set to 100%. Mean values   SEM
(n   6) are shown. *, P   0.05, paired t test. (B) NCAM immunoprecipitates (IP: NCAM) from wild-type (RPTP  / ) and RPTP -deficient (RPTP  / )
brain homogenates were probed with antibodies against NCAM and p59
fyn by Western blot. Note that p59
fyn coimmunoprecipitates with NCAM in wild-
type but not in RPTP -deficient brains. (C) Wild-type and RPTP -deficient hippocampal neurons were incubated live with NCAM antibodies to cluster
NCAM. Cells were fixed and labeled with antibodies against p59
fyn. Note that redistribution of p59
fyn to NCAM clusters was reduced in RPTP -deficient
neurons. Bar, 10  m. The corresponding profiles show NCAM and p59
fyn labeling intensities along neurites. The histogram shows mean labeling intensity
of p59
fyn in NCAM clusters. Mean values   SEM (n   20 neurons) are shown in arbitrary units (AU). *, P   0.05, t test. (D) Wild-type and RPTP -deficient
hippocampal neurons were incubated live with nonspecific IgG or NCAM antibodies, and fixed and labeled with antibodies against p59
fyn dephosphory-
lated at Tyr-531. Immunofluorescence signals were inverted to accentuate the difference in immunolabeling intensities between groups. Bar, 10  m. Note
that application of NCAM antibodies increased levels of p59
fyn dephosphorylated at Tyr-531 in wild type, but not in RPTP -deficient neurons. The histogram
shows mean labeling intensity of p59
fyn dephosphorylated at Tyr-531 along neurites. Mean values   SEM (n   20 neurons) are shown in arbitrary
units (AU). *, P   0.05, t test.RPTP  LINKS NCAM TO P59
FYN PATHWAY • BODRIKOV ET AL. 133
RPTP C433S inhibit NCAM–p59
fyn complex formation by
competing with endogenous RPTP . The combined observa-
tions indicate that NCAM140–p59
fyn complex formation
correlates with the ability of NCAM140-associated RPTP 
to bind to p59
fyn, implicating RPTP  as a linker between
NCAM140 and p59
fyn.
Association between NCAM and p59
fyn 
and NCAM-mediated p59
fyn activation 
are abolished in RPTP -deficient neurons
To substantiate further our finding that RPTP  is a linker pro-
tein between NCAM and p59
fyn, we analyzed p59
fyn activation
and association of p59
fyn with NCAM in RPTP -deficient
brains. As for NCAM-deficient brains, levels of p59
fyn dephos-
phorylated at Tyr-531 and levels of p59
fyn phosphorylated at
Tyr-420 were reduced in brain homogenates of RPTP -defi-
cient mice (Fig. 5 A), further suggesting that RPTP  plays a
role in NCAM-mediated p59
fyn activation in the brain. To ana-
lyze the role of RPTP  in the formation of the complex be-
tween NCAM and p59
fyn, we immunoprecipitated NCAM from
wild-type and RPTP -deficient brains and probed immunopre-
cipitates with antibodies against p59
fyn. Whereas p59
fyn coim-
munoprecipitated with NCAM from wild-type brains, p59
fyn did
not coimmunoprecipitate with NCAM from RPTP -deficient
brains (Fig. 5 B). Furthermore, when NCAM was clustered at
the surface of wild-type and RPTP -deficient cultured hippo-
campal neurons, levels of p59
fyn were significantly reduced in
NCAM clusters in RPTP -deficient neurons when compared
with wild-type cells (Fig. 5 C), indicating that RPTP  is re-
quired for complex formation between NCAM and p59
fyn.
NCAM clustering at the cell surface induces rapid p59
fyn
activation (Beggs et al., 1997). To analyze whether or not
RPTP  is required for NCAM-induced p59
fyn activation, we
treated live hippocampal neurons from wild-type and RPTP -
deficient mice with NCAM antibodies and analyzed levels of
p59
fyn dephosphorylated at Tyr-531 along neurites of the stimu-
lated neurons. Clustering of NCAM increased levels of Tyr-
531–dephosphorylated p59
fyn along neurites of wild-type neu-
Figure 6. NCAM–RPTP  complex formation is enhanced
by spectrin in a Ca
2 -dependent manner. (A) NCAM
immunoprecipitates obtained from brain homogenates of
wild-type mice ( / ) in the presence or absence of 2 mM
EDTA were probed by Western blot with antibodies
against RPTP . NCAM-deficient brains ( / ) were taken
for control. Coimmunoprecipitation of RPTP  was inhib-
ited by EDTA application. The histogram shows quantita-
tion of the blots. (B) Intracellular domains of NCAM140
were bound to plastic and assayed by ELISA for the ability
to bind increasing concentrations of RPTP  intracellular
domains in the absence of Ca
2  or in the presence of 2 mM
Ca
2 . Binding to BSA served as a control. Mean values
(OD 405)   SEM (n   6) are shown. Binding of intracel-
lular domains of RPTP  to intracellular domains of
NCAM140 did not depend on Ca
2 . (C) Spectrin immu-
noprecipitates obtained from brain homogenates of wild-
type mice in the absence or presence of 2 mM EDTA
were probed by Western blot with antibodies against
RPTP  or NCAM. Non-immune rabbit Ig (control Ig) were
used for control. Coimmunoprecipitation of RPTP  with
spectrin was inhibited by EDTA, whereas coimmunoprecipi-
tation of NCAM did not depend on Ca
2 . Histograms show
quantitation of the blots. For histograms in A and C, OD in
the presence of Ca
2  was set to 100% and mean values  
SEM (n   6) are shown. *, P   0.05, paired t test.JCB • VOLUME 168 • NUMBER 1 • 2005 134
rons by  60% (Fig. 5 D). However, NCAM-mediated p59
fyn
activation was completely abolished in RPTP -deficient neu-
rons (Fig. 5 D), demonstrating that RPTP  is required for
NCAM-mediated p59
fyn activation.
Formation of the complex between 
RPTP  and NCAM is enhanced by Ca
2 
Coimmunoprecipitation experiments were performed either in
the presence of Ca
2  or with 2 mM EDTA, a Ca
2 -sequestering
agent. Whereas RPTP  coimmunoprecipitated with NCAM
from brain homogenates under both conditions, coimmuno-
precipitated complexes were reduced by  60% in the presence
of EDTA (Fig. 6 A), suggesting that Ca
2  promotes formation
of the NCAM–RPTP  complex. These results are in accor-
dance with findings of Zeng et al. (1999), who found that
NCAM and RPTP  did not coimmunoprecipitate in the pres-
ence of EDTA. To analyze if the direct interaction between
NCAM and RPTP  is Ca
2  dependent, we assayed binding of
the intracellular domain of NCAM140 to the intracellular do-
main of RPTP  by ELISA in the presence or absence of Ca
2 
(Fig. 6 B), showing that the direct interaction is Ca
2  inde-
pendent and suggesting that additional binding partners of
NCAM and/or RPTP  may enhance complex formation in a
Ca
2 -dependent manner. Spectrin, which directly interacts
with the intracellular domain of NCAM (Leshchyns’ka et al.,
2003) and contains a Ca
2  binding domain (De Matteis and
Morrow, 2000), is one of the possible candidates. Indeed,
RPTP  coimmunoprecipitated with spectrin from brain ho-
mogenates (Fig. 6 C). In the presence of 2 mM EDTA,
RPTP  coimmunoprecipitating with spectrin was reduced by
 80% (Fig. 6 C), whereas coimmunoprecipitation of NCAM
with spectrin did not depend on Ca
2  (Fig. 6 C). We conclude
that RPTP  directly interacts with NCAM in a Ca
2 -indepen-
dent manner. However, formation of the complex is enhanced
by Ca
2 -dependent cross-linking of NCAM140 and RPTP 
via spectrin.
Figure 7. NCAM activation induces redistri-
bution of RPTP  to lipid rafts. (A–D and F)
Control hippocampal neurons and neurons
incubated with corresponding reagents were
extracted in cold 1% Triton X-100 and labeled
with antibodies against NCAM and RPTP 
together with FITC-labeled cholera toxin to
visualize GM1-containing lipid rafts. (A) Note
increased overlap of NCAM with RPTP  and
GM1 after NCAM-Fc application when com-
pared with control neurons (arrows). Bar, 10
 m. (B and C) Histograms show mean intensi-
ties of RPTP  and GM1 in NCAM clusters in
control and NCAM-Fc (B) or NCAM antibody
(C)–treated neurons. (D) Histograms show
mean intensities of NCAM and GM1 in RPTP 
clusters in control and NCAM antibody–
treated neurons. (E) Lipid rafts obtained from
wild-type ( / ) or NCAM-deficient brains
( / ) were probed by Western blot (WB)
with antibodies against RPTP  or p59
fyn or by
dot blot (DB) with cholera toxin. Note reduced
amount of RPTP  in rafts from NCAM-deficient
brains. The histogram shows quantitation of
the RPTP  levels in lipid rafts. OD in wild type
was set to 100% and mean values   SEM
(n   6) are shown. *, P   0.05, paired t test.
(F) Hippocampal neurons were incubated with
nonspecific IgG or NCAM antibody alone, or
in the presence of BAPTA-AM or FGFR inhibi-
tor. Graphs show mean labeling intensity of
RPTP  and GM1 in NCAM clusters. Note that
treatment with BAPTA-AM and FGFR inhibitor
abolished redistribution of RPTP  to NCAM
clusters but not redistribution of NCAM to
GM1-positive  rafts.  Histograms (B–D and F)
show mean values   SEM (n   50) in arbitrary
units (AU). *, P   0.05, t test.RPTP  LINKS NCAM TO P59
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The NCAM–RPTP  complex redistributes 
to lipid rafts after NCAM activation
Whereas p59
fyn is mainly associated with lipid rafts (van’t
Hof and Resh, 1997; Niethammer et al., 2002; Filipp et al.,
2003), only 4–8% of all RPTP  molecules were found in
lipid rafts of brain (unpublished data). In hippocampal neu-
rons extracted with cold 1% Triton X-100 to isolate lipid rafts
(Niethammer et al., 2002; Leshchyns’ka et al., 2003), deter-
gent-insoluble clusters of RPTP  only partially overlapped
with the lipid raft marker ganglioside GM1 (Fig. 7 A), further
confirming that RPTP  and p59
fyn are segregated at the sub-
cellular level. Because activation of NCAM results in its re-
distribution to lipid rafts (Leshchyns’ka et al., 2003), it may
also promote redistribution of NCAM-associated RPTP  to
lipid rafts and thus activate raft-associated p59
fyn. To verify
this hypothesis, we studied association of NCAM and RPTP 
with lipid rafts in hippocampal neurons activated or not acti-
vated with NCAM-Fc or NCAM antibodies. In accordance
with previous results (Leshchyns’ka et al., 2003), application
of NCAM-Fc or NCAM antibodies increased GM1 levels in
detergent-insoluble clusters of NCAM, indicating that NCAM
redistributed to lipid rafts (Fig. 7, A–C). Application of
NCAM-Fc or NCAM antibodies also increased the level of
RPTP  in NCAM clusters, indicating that NCAM activation
promoted NCAM–RPTP  complex formation (Fig. 7, A–C).
Furthermore, NCAM activation also increased GM1 levels in
detergent-insoluble clusters of RPTP  (Fig. 7 D), confirming
that NCAM-associated RPTP  also redistributed to lipid rafts
and suggesting that NCAM recruits RPTP  to lipid rafts.
To further analyze this possibility, we compared levels of
RPTP  in lipid rafts in brains of wild-type and NCAM-defi-
cient mice. Indeed, RPTP  was reduced by  60% in lipid
rafts isolated from NCAM-deficient brains (Fig. 7 E), con-
firming that NCAM plays a role in RPTP  targeting to lipid
rafts. The levels of p59
fyn were increased in NCAM-deficient
lipid rafts (100% and 124   7.6% in wild-type and NCAM
deficient rafts, respectively) probably reflecting increased
levels of p59
fyn in NCAM-deficient brains. Levels of GM1
were not different in lipid rafts from wild-type and NCAM-
deficient brains (100% and 103.3   6.8% in wild-type and
NCAM-deficient rafts, respectively), showing that lipid rafts
were isolated with the same efficacy from wild-type and
NCAM-deficient brains (Fig. 7 E).
NCAM-mediated recruitment of RPTP  
to lipid rafts is enhanced by NCAM-
induced FGF receptor (FGFR)–dependent 
increase in intracellular Ca
2 
NCAM activation increases intracellular Ca
2  concentrations
via a FGFR-dependent mechanism (Walsh and Doherty,
1997; Kamiguchi and Lemmon, 2000; Juliano, 2002). This
increase in intracellular Ca
2  may account for the enhanced
association between NCAM and RPTP  after NCAM activa-
tion (Fig. 7, A–D) because of spectrin-mediated cross-linking
of NCAM140 and RPTP  (Fig. 6). Interestingly, NCAM acti-
vation also induces redistribution of NCAM-associated spec-
trin to lipid rafts (Leshchyns’ka et al., 2003). To analyze the
role of FGFR and Ca
2  in the recruitment of RPTP  to an
NCAM complex, we estimated levels of RPTP  associated
with NCAM following NCAM activation in control neurons
and neurons incubated with BAPTA-AM, a membrane-per-
meable Ca
2  chelator (Williams et al., 1992; Cavallaro et al.,
Figure 8. NCAM-mediated neurite outgrowth depends on RPTP  activation.
(A) Hippocampal neurons were incubated with NCAM-Fc alone or with
NCAM-Fc together with vanadate, and lengths of the longest neurites
were measured. NCAM-Fc increased neurite length when compared with
control neurons. Vanadate decreased neurite outgrowth in the NCAM-Fc–
stimulated group to the control group level but did not affect basal neurite
outgrowth over poly-L-lysine. (B) Hippocampal neurons transfected with
GFP alone or cotransfected with GFP and RPTP C433S or RPTP  D2
were incubated with NCAM-Fc after transfection and lengths of the long-
est neurites were measured. NCAM-Fc increased neurite lengths in GFP-
transfected neurons. NCAM-Fc–stimulated neurite outgrowth was blocked
in the group cotransfected with RPTP C433S or RPTP  D2. (C) Lengths of
the longest neurites were measured in wild-type ( / ) and RPTP -deficient
( / ) neurons not treated or treated with NCAM-Fc. NCAM-Fc increased
neurite length in wild-type but not in RPTP -deficient neurons. For A–C,
mean values   SEM are shown (n   150 neurons; *, P   0.05, t test).
Experiments were performed two times with the same effect.JCB • VOLUME 168 • NUMBER 1 • 2005 136
2001), or a specific FGFR inhibitor (Niethammer et al., 2002;
Leshchyns’ka et al., 2003). Whereas NCAM activation in-
creased levels of RPTP  and GM1 in NCAM clusters (Fig. 7
F), treatment with BAPTA-AM or FGFR inhibitor abolished
recruitment of RPTP  to NCAM clusters in response to
NCAM activation (Fig. 7 F). In accordance with previous
findings (Leshchyns’ka et al., 2003), NCAM redistribution to
lipid rafts was not affected by the FGFR inhibitor or BAPTA-
AM (Fig. 7 F). BAPTA-AM or FGFR inhibitor did not affect
the level of RPTP  associated with NCAM under nonacti-
vated conditions (Fig. 7 F). We conclude that, whereas at
resting conditions Ca
2  does not play a major role in the
interaction between NCAM and RPTP , NCAM-induced
FGFR-dependent elevations of intracellular Ca
2  levels
strengthen the interactions between NCAM and RPTP  in re-
sponse to NCAM activation, most likely via spectrin (see the
section  Formation of the complex between RPTP  and
NCAM is enhanced by Ca
2 ).
NCAM-induced neurite outgrowth 
depends on NCAM association with 
RPTP 
NCAM-induced neurite outgrowth depends on p59
fyn activa-
tion (Kolkova et al., 2000), suggesting that NCAM associa-
tion with RPTP  may be involved. To analyze the role of
protein tyrosine phosphatases in NCAM-induced neurite
outgrowth, we incubated cultured hippocampal neurons
with 100  M vanadate, an inhibitor of these phosphatases
(Helmke et al., 1998). NCAM-Fc–enhanced neurite out-
growth was abolished by vanadate, indicating that activation
of protein tyrosine phosphatases is required for NCAM-medi-
ated neurite outgrowth. Vanadate did not affect neurite out-
growth in nonstimulated neurons, indicating that vanadate
does not lead to nonspecific impairments (Fig. 8 A). To di-
rectly assess the role of RPTP  in NCAM-induced neurite
outgrowth, we transfected hippocampal neurons with the
dominant-negative mutants of RPTP . Both, RPTP  D2,
which does not bind NCAM but associates with p59
fyn, and
catalytically inactive RPTP C433S, which associates with
NCAM but binds p59
fyn with a lower efficiency than endoge-
nous RPTP , inhibited association of NCAM with p59
fyn by
competing with endogenous RPTP  (Fig. 4). In neurons
transfected with GFP only, stimulation with NCAM-Fc sig-
nificantly enhanced neurite length when compared with con-
trol nonstimulated neurons (Fig. 8 B). However, neurons
transfected with RPTP  D2 or RPTP C433S remained un-
responsive to NCAM-Fc stimulation (Fig. 8 B), indicating
that RPTP  plays a major role in NCAM-induced neurite out-
growth. To confirm this finding, we analyzed NCAM-medi-
ated neurite outgrowth in hippocampal neurons from RPTP -
deficient mice. Whereas NCAM-Fc enhanced neurite out-
growth in neurons from RPTP  wild-type littermates by
 100%, NCAM-Fc–induced neurite outgrowth was com-
pletely abolished in RPTP -deficient neurons (Fig. 8 C), fur-
ther confirming that RPTP  is required for NCAM-mediated
neurite outgrowth.
Figure 9. A proposed model of NCAM140-
mediated p59
fyn activation cascade. Before
NCAM activation, NCAM140 and RPTP 
located predominantly in raft-free areas are
segregated from p59
fyn, which predominantly
associates with lipid rafts. NCAM activation
induces FGFR-dependent increase in intracel-
lular Ca
2  that enhances RPTP –NCAM140
complex formation via spectrin as a cross-
linking platform. Additionally, NCAM activa-
tion results in the redistribution of the complex
to lipid rafts due to NCAM palmitoylation.
In lipid rafts, RPTP  binds and dephosphory-
lates p59
fyn resulting in p59
fyn activation,
which, in turn, promotes neurite outgrowth.RPTP  LINKS NCAM TO P59
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Discussion
It is by now well established that in response to homophilic or
heterophilic binding cell adhesion molecules of the immuno-
globulin superfamily, such as NCAM, L1, or CHL1, activate
Src family tyrosine kinases, and in particular pp60
c-src or
p59
fyn, resulting in morphogenetic events, such as cell migra-
tion and neurite outgrowth. However, the mechanisms of Src
family tyrosine kinase activation in these paradigms have re-
mained unresolved. Here, we identify a cognate activator of
p59
fyn, the receptor protein tyrosine phosphatase RPTP , as
a novel binding partner of NCAM. Activation of p59
fyn is
reduced in NCAM-deficient mice and interaction between
NCAM and p59
fyn is abolished in RPTP -deficient brains. In-
terestingly, we found that the levels of p59
fyn and RPTP  are
increased in NCAM-deficient brains, possibly reflecting a
compensatory reaction to the decreased activity of these en-
zymes in the mutant and further indicating a tight functional
relationship between NCAM, RPTP , and p59
fyn. NCAM-
induced neurite outgrowth is completely abrogated in RPTP -
deficient neurons or in neurons transfected with dominant-
negative RPTP  mutants, indicating that RPTP  links NCAM
to p59
fyn both physically and functionally.
Role of Ca
2  in NCAM–RPTP –p59
fyn 
complex formation
Interactions between NCAM and RPTP  and NCAM–
RPTP –p59
fyn complex formation leading to neurite out-
growth are tightly regulated (Fig. 9). First, whereas direct in-
teraction between NCAM and RPTP  is Ca
2  independent,
NCAM–RPTP  complex formation is enhanced by Ca
2 -
dependent cross-linking via spectrin. Remarkably, NCAM ac-
tivation results in an increase in intracellular Ca
2  concentration
via influx through Ca
2  channels or release from intracellular
stores, and may thus provide a positive feedback loop between
NCAM activation and NCAM–RPTP  complex formation
involving spectrin. RPTP  binding to spectrin may also ele-
vate RPTP  enzymatic dephosphorylation activity (Lokesh-
war and Bourguignon, 1992). Interestingly, NCAM activation
also induces activation of PKC (Kolkova et al., 2000; Lesh-
chyns’ka et al., 2003), which is known to phosphorylate
RPTP  and stimulate its activity (den Hertog et al., 1995;
Tracy et al., 1995; Zheng et al., 2002). Thus, a network of acti-
vated intracellular signaling molecules may underlie the in-
duction and maintenance of NCAM-mediated neurite out-
growth. It is interesting in this respect that the NCAM140
isoform predominates in these interactions: it interacts more
efficiently with p59
fyn via RPTP  and enhances neurite out-
growth more vigorously than NCAM180 (Niethammer et al.,
2002). The structural dispositions of NCAM140 for this pref-
erence will remain to be established.
The role of lipid rafts
Additional regulation of RPTP -mediated p59
fyn activation is
achieved by segregation of RPTP  and p59
fyn to different sub-
domains in the plasma membrane (Fig. 9). Approximately 90%
of all RPTP  molecules in the brain are located in a lipid raft-
free environment and are thereby segregated from lipid raft-
associated p59
fyn under nonstimulated conditions. Whereas
segregation of receptor protein tyrosine phosphatases from
their potential substrates due to targeting to different plasma
membrane domains has been suggested as a general mecha-
nism of the regulation of receptor protein tyrosine phosphatase
function (Petrone and Sap, 2000), the mechanisms that target
receptor protein tyrosine phosphatases to lipid rafts have re-
mained unclear. We show that levels of raft-associated RPTP 
in the NCAM-deficient brain are reduced, and NCAM redistri-
bution to lipid rafts in response to NCAM activation also in-
duces redistribution of RPTP  to lipid rafts via its NCAM as-
sociation. The combined observations indicate that NCAM
plays a role in recruiting NCAM-associated RPTP  to lipid
rafts via NCAM palmitoylation (Niethammer et al., 2002; Fig.
9) or via NCAM interaction with GPI-anchored components of
lipid rafts, such as the GPI-linked GDNF receptor (Paratcha et
al., 2003). Investigations on the regulatory mechanisms un-
derlying palmitoylation will be required to understand the
subcellular compartment-specific distribution of the NCAM–
RPTP –p59
fyn complex. Furthermore, the localization of adhe-
sion molecules and receptors will have to be elucidated in view
of lipid rafts heterogeneities.
Potential role of protein tyrosine 
phosphatases in signaling mediated by 
other cell adhesion molecules
Besides NCAM, activation of L1 and CHL1, other cell adhesion
molecules of the immunoglobulin superfamily, also results in the
activation of Src family tyrosine kinases (Schmid et al., 2000;
Buhusi et al., 2003). As for NCAM, the intracellular domains of
L1 and CHL1 do not possess structural motif for protein tyrosine
phosphatase activity, suggesting that yet unidentified protein ty-
rosine phosphatases may be involved. Identification of protein
tyrosine phosphatases associated with other cell adhesion mole-
cules of the immunoglobulin superfamily and conjunctions with
RPTP -activated integrins (Zeng et al., 2003) will be an impor-
tant next step in the elucidation of the mechanisms that cell adhe-
sion molecules use differentially to guide cell migration and neu-
rite outgrowth in the developing nervous system.
Materials and methods
Antibodies and toxins
Rabbit polyclonal antibodies against NCAM (Niethammer et al., 2002)
were used in immunoprecipitation, immunoblotting, and immunocy-
tochemical experiments; and rat mAbs H28 against mouse NCAM
(Gennarini et al., 1984) were used in immunocytochemical experi-
ments. Both antibodies recognize the extracellular domain of all NCAM
isoforms. Hybridoma clone H28 was a gift of C. Goridis (Centre Na-
tional de la Recherche Scientifique UMR 8542, Paris, France). Rabbit
antibodies against RPTP  were a gift of C.J. Pallen (University of British
Columbia, Vancouver, Canada) or were generated as described previ-
ously (den Hertog et al., 1994). Rabbit polyclonal antibodies against
human erythrocyte spectrin, rabbit polyclonal antibodies against the HA
tag, nonspecific rabbit immunoglobulins, and cholera toxin B subunit
tagged with fluorescein to label GM1 were obtained from Sigma-
Aldrich. Mouse mAbs against the HA tag (clone 12CA5) were obtained
from Roche Diagnostics. Rabbit polyclonal antibodies and mouse mAbs
against p59
fyn protein were purchased from Santa Cruz Biotechnology,
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Tyr-416–phosphorylated pp60
c-src kinase that cross-react with Tyr-531–
dephosphorylated or Tyr-420–phosphorylated p59
fyn were obtained
from Cell Signaling Technology. Secondary antibodies against rabbit,
rat, and mouse Ig coupled to HRP, Cy2, Cy3, or Cy5 were obtained
from Dianova.
Animals
To compare wild-type and NCAM-deficient mice, C57BL/6J mice and
NCAM-deficient mice (Cremer et al., 1994) inbred for at least nine gener-
ations onto the C57BL/6J background were used. NCAM-deficient mice
were a gift of H. Cremer (Developmental Biology Institute of Marseille,
Marseille, France).To compare wild-type and RPTP -deficient mice, RPTP -
positive and -negative littermates obtained from heterozygous breeding
were used (see online supplemental material).
Image acquisition and manipulation
Coverslips were embedded in Aqua-Poly/Mount (Polysciences, Inc.). Im-
ages were acquired at RT using a confocal laser scanning microscope
(model LSM510; Carl Zeiss MicroImaging, Inc.), LSM510 software (ver-
sion 3; Carl Zeiss MicroImaging, Inc.), and oil Plan-Neofluar 40  objec-
tive (NA 1.3; Carl Zeiss MicroImaging, Inc.) at 3  digital zoom. Con-
trast and brightness of the images were further adjusted in Photo-Paint 9
(Corel Corporation).
Detergent extraction of cultured neurons
Cells washed in PBS were incubated for 1 min in cold microtubule-stabiliz-
ing buffer (2 mM MgCl2, 10 mM EGTA, and 60 mM Pipes, pH 7.0) and
extracted 8 min on ice with 1% Triton X-100 in microtubule-stabilizing
buffer as described previously (Ledesma et al., 1998). After washing with
PBS, cells were fixed with cold 4% formaldehyde in PBS.
Colocalization analysis
Colocalization quantification was performed as described previously
(Leshchyns’ka et al., 2003). In brief, an NCAM cluster was defined as an
accumulation of NCAM labeling with a mean intensity at least 30%
higher than background. NCAM clusters were automatically outlined us-
ing the threshold function of the Scion Image software (Scion Corpora-
tion). Within the outlined areas the mean intensities of NCAM, RPTP ,
p59
fyn, or GM1 labeling associated with NCAM cluster were measured.
The same threshold was used for all groups. All experiments were per-
formed two to three times with the same effect. Colocalization profiles
were plotted using ImageJ software (National Institutes of Health).
DNA constructs
Rat NCAM140 and NCAM180/pcDNA3 were a gift of P. Maness (Uni-
versity of North Carolina, Chapel Hill, NC). Rat NCAM120 (a gift of E.
Bock, University of Copenhagen, Copenhagen, Denmark) was sub-
cloned into the pcDNA3 vector (Invitrogen) by two EcoRI sites. The EGFP
plasmid was purchased from CLONTECH Laboratories, Inc. cDNAs en-
coding intracellular domains of NCAM140 and NCAM180 were as de-
scribed previously (Sytnyk et al., 2002; Leshchyns’ka et al., 2003).
The plasmid encoding the intracellular domain of RPTP  was a gift of
C.J. Pallen. Wild-type RPTP , RPTP C433S, and RPTP  D2 (containing
RPTP  residues 1–516 [last 6 residues: KIYNKI]) were as described pre-
viously (den Hertog and Hunter, 1996; Blanchetot and den Hertog,
2000; Buist et al., 2000).
Online supplemental material
Details on cultures and transfection of hippocampal neurons and CHO
cells, immunofluorescence labeling, ELISA and pull-down assay, coimmu-
noprecipitation, isolation of lipid enriched microdomains, gel electrophore-
sis, immunoblotting, and generation of RPTP -deficient mice are given in
online supplemental material. Online supplemental material is available at
http://www.jcb.org/cgi/content/full/jcb.200405073/DC1.
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